OctreoScan

WikiDoc Resources for OctreoScan
Articles
Most recent articles on OctreoScan Most cited articles on OctreoScan Review articles on OctreoScan Articles on OctreoScan in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on OctreoScan Images of OctreoScan Photos of OctreoScan Podcasts & MP3s on OctreoScan Videos on OctreoScan
Evidence Based Medicine
Cochrane Collaboration on OctreoScan Bandolier on OctreoScan TRIP on OctreoScan
Clinical Trials
Ongoing Trials on OctreoScan at Clinical Trials.gov Trial results on OctreoScan Clinical Trials on OctreoScan at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on OctreoScan NICE Guidance on OctreoScan NHS PRODIGY Guidance FDA on OctreoScan CDC on OctreoScan
Books
Books on OctreoScan
News
OctreoScan in the news Be alerted to news on OctreoScan News trends on OctreoScan
Commentary
Blogs on OctreoScan
Definitions
Definitions of OctreoScan
Patient Resources / Community
Patient resources on OctreoScan Discussion groups on OctreoScan Patient Handouts on OctreoScan Directions to Hospitals Treating OctreoScan Risk calculators and risk factors for OctreoScan
Healthcare Provider Resources
Symptoms of OctreoScan Causes & Risk Factors for OctreoScan Diagnostic studies for OctreoScan Treatment of OctreoScan
Continuing Medical Education (CME)
CME Programs on OctreoScan
International
OctreoScan en Espanol OctreoScan en Francais
Business
OctreoScan in the Marketplace Patents on OctreoScan
Experimental / Informatics
List of terms related to OctreoScan

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Indications for OctreoScan imaging

• Tumor evaluation

• Pheochromocytoma
• Paraganglioma
• Islet cell tumor
• Carcinoid
• Medullary carcinoma of thyroid
• Small cell lung cancer
• Neuroblastoma
• Pituitary adenoma
• Lymphoma
• Breast cancer
• Astrocytoma
• Meningioma
• Thymoma

Patient preparation

• Bowel preparation with laxative and enema
• Discontinue octeotide therapy for 1 week prior the exam

Radiopharmaceutical

• In-111 OctreoScan

Dose and route of administration

• 6 mCi IV
  • 4 hours (abdomen, pelvis)
  • 24 hours (whole body)

Equipment

• Camera: Large field of view SPECT gamma camera
• Collimator: Medium-energy
• Window: 20% window around 173 and 245 KeV

Procedure

• 4 hours: Planar images of the abdomen and pelvis
• 24 hours: Planar images of the whole body. SPECT of regions of clinical concern.

Images

Normal OctreoScan

Image:Normal-octreoscan-001.jpg Image:Normal-octreoscan-002.jpg Image:Normal-octreoscan-003.jpg Image:Normal-octreoscan-004.jpg Image:Normal-octreoscan-005.jpg Image:Normal-octreoscan-006.jpg

References

• Ziessman, Harvey A, O'Malley, Janis P, and Thrall, James M. Nuclear Medicine: The Requisites. 3rd ed. Philadelphia, Pennsylvania: Mosby, 2006. ISBN 0323029469